Epilepsy Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

May 2019| TMR1603A| Transparency

Report Highlights

Global Epilepsy Therapeutics Market: Overview

This report analyzes the global epilepsy therapeutics market in terms of its current and future scenario. Epilepsy is a central nervous system disorder in which the brain activity becomes abnormal, thereby resulting in periods of unusual behavior or seizures, sensations, and sometimes, even loss of awareness. Epilepsy is generally diagnosed after a person has experienced at least two seizures that didn’t occur due to known medical condition; for instance, extremely low blood sugar or alcohol withdrawal. The treatment of epilepsy can be carried out with antiepileptic medications (AEDs), diet therapy, and surgery. Epilepsy therapeutics or medications are the starting treatment choice for almost all patients with multiple seizures. According to American Association of Neurological Surgeons, epilepsy therapeutics are significantly effective and completely control seizures in a majority (approximately 70%) of patients. The drugs prevent seizures by decreasing the tendency of the brain cells to send excessive and confused electrical impulses.

This report on the global epilepsy therapeutics market comprises an elaborate executive summary, including a market snapshot that provides information about different segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product, distribution channel, and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Moreover, the section comprises the company profiles with a business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the epilepsy therapeutics market.

Global Epilepsy Therapeutics Market: Key Segments

Based on product, the global epilepsy therapeutics market has been segmented into first generation epilepsy therapeutics, second generation epilepsy therapeutics, and third generation epilepsy therapeutics. In terms of distribution channel, the global epilepsy therapeutics market has been classified into hospital pharmacy, retail pharmacy, and online pharmacy. The global epilepsy therapeutics market has been analyzed based on approvals and launches of products, research and developmental activities, and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2017 to 2027, along with their respective CAGR for the forecast period from 2019 to 2027, considering 2018 as the base year.

Global Epilepsy Therapeutics Market: Regional Outlook

In terms of region, the global epilepsy therapeutics  market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (Germany, the U.K., France, Italy, Russia, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC countries, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period from 2017 to 2027, along with their respective CAGR for the forecast period 2019-2027, considering 2018 as the base year. This report also covers the competitive scenario of the market in these regions.

Companies Mentioned in Report

The report profiles major players operating in the global epilepsy therapeutics market in terms of attributes such as company overview, financial overview, product portfolio, and business strategies. Major companies profiled in this report are Pfizer, Inc., UCB S.A., Bausch Health Companies Inc., Novartis AG, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc., Eisai Co., Upsher-Smith Laboratories, LLC., and Amneal Pharmaceuticals LLC.

The global epilepsy therapeutics market has been segmented as mentioned below:

Global Epilepsy Therapeutics Market, by Product

First Generation Epilepsy Therapeutics
Second Generation Epilepsy Therapeutics
Third Generation Epilepsy Therapeutics
Global Epilepsy Therapeutics Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Epilepsy Therapeutics Market, by Region

North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product,2017-2027
  • Table 2 : Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 3 : Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Region,2017-2027
  • Table 4 : North America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country,2017-2027
  • Table 5 : North America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product,2017-2027
  • Table 6 : North America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel ,2017-2027
  • Table 7 : Europe Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 8 : Europe Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product,2017-2027
  • Table 9 : Europe Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 10 : Asia Pacific Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 11 : Asia Pacific Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product,2017-2027
  • Table 12 : Asia Pacific Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 13 : Latin America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 14 : Latin America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product,2017-2027
  • Table 15 : Latin America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 16 : Middle East & Africa Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 17 : Middle East & Africa Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product,2017-2027
  • Table 18 : Middle East & Africa Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Figure 1 : Global Epilepsy Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 2 : Global Epilepsy Therapeutics Market Value (US$ Mn), by Product, 2018
  • Figure 3 : Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,2017-2027
  • Figure 4 : Global Epilepsy Therapeutics Market Value Share (%), by Product, 2018 and 2027
  • Figure 5 : Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by First Generation Epilepsy Therapeutics,2017-2027
  • Figure 6 : Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Second Generation Epilepsy Therapeutics,2017-2027
  • Figure 7 : Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Third Generation Epilepsy Therapeutics,2017-2027
  • Figure 8 : Global Epilepsy Therapeutics Market Attractiveness Analysis, by Product, 2019–2027
  • Figure 9 : Global Epilepsy Therapeutics Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 10 : Global Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 11 : Global Epilepsy Therapeutics Market Value (US$ Mn) and Y-o-Y Growth, by Hospital Pharmacy,2017-2027
  • Figure 12 : Global Epilepsy Therapeutics Market Value (US$ Mn) and Y-o-Y Growth, by Retail Pharmacy ,2017-2027
  • Figure 13 : Global Epilepsy Therapeutics Market Value (US$ Mn) and Y-o-Y Growth, by Online Pharmacy,2017-2027
  • Figure 14 : Global Epilepsy Therapeutics Market Value Share, by Region, 2018 and 2027
  • Figure 15 : Global Epilepsy Therapeutics Market Attractiveness, by Region, 2019–2027
  • Figure 16 : North America Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 17 : North America Epilepsy Therapeutics Market Value Share (%), by Country, 2018 and 2027
  • Figure 18 : North America Epilepsy Therapeutics Market Attractiveness, by Country, 2019–2027
  • Figure 19 : North America Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
  • Figure 20 : North America Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
  • Figure 21 : North America Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 22 : North America Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 23 : Europe Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 24 : Europe Epilepsy Therapeutics Market Value Share (%), by Country / Sub-region, 2018 and 2027
  • Figure 25 : Europe Epilepsy Therapeutics Market Attractiveness, by Country / Sub-region, 2019–2027
  • Figure 26 : Europe Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
  • Figure 27 : Europe Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
  • Figure 28 : Europe Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 29 : Europe Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 30 : Asia Pacific Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 31 : Asia Pacific Epilepsy Therapeutics Market Value Share (%), by Country/Sub-region, 2018 and 2027
  • Figure 32 : Asia Pacific Epilepsy Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 33 : Asia Pacific Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
  • Figure 34 : Asia Pacific Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
  • Figure 35 : Asia Pacific Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 36 : Asia Pacific Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 37 : Latin America Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 38 : Latin America Epilepsy Therapeutics Market Value Share (%), by Country / Sub-region, 2018 and 2027
  • Figure 39 : Europe Epilepsy Therapeutics Market Attractiveness, by Country / Sub-region, 2019–2027
  • Figure 40 : Latin America Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
  • Figure 41 : Latin America Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
  • Figure 42 : Latin America Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 43 : Latin America Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 44 : Middle East & Africa Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 45 : Middle East & Africa Epilepsy Therapeutics Market Value Share (%), by Country/Sub-region, 2018 and 2027
  • Figure 46 : Middle East & Africa Epilepsy Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 47 : Middle East & Africa Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
  • Figure 48 : Middle East & Africa Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
  • Figure 49 : Middle East & Africa Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 50 : Middle East & Africa Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 51 : Pfizer, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
  • Figure 52 : Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
  • Figure 53 : Pfizer, Inc. Breakdown of Net Sales, by Geography 2018
  • Figure 54 : Pfizer, Inc. Breakdown of Net Sales, by Business Segments (%), 2018
  • Figure 55 : Bausch Health Companies Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 56 : Bausch Health Companies Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 57 : Bausch Health Companies Inc. Breakdown of Net Sales (%), by Region, 2017
  • Figure 58 : Bausch Health Companies Inc. Breakdown of Revenues(%), by Product Category, 2017
  • Figure 59 : UCB S.A. Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2018
  • Figure 60 : UCB S.A. R&D Intensity and Sales & Marketing Intensity - Company Level, 2017–2018
  • Figure 61 : UCB S.A. Breakdown of Net Sales, by Region, 2018
  • Figure 62 : UCB S.A. Breakdown of Net Sales, by Therapeutic Area, 2018
  • Figure 63 : Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2018
  • Figure 64 : Novartis AG R&D Intensity and Sales & Marketing Intensity - Company Level, 2017–2018
  • Figure 65 : Novartis AG Breakdown of Net Sales, by Region, 2018
  • Figure 66 : Novartis AG Breakdown of Net Sales, by Business Segment, 2018
  • Figure 67 : GlaxoSmithKline plc. Sales Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
  • Figure 68 : GlaxoSmithKline plc. Breakdown of R&D Expenditure (US$ Mn), 2016-2018
  • Figure 69 : GlaxoSmithKline plc. Breakdown of Net Sales, by Region, 2018
  • Figure 70 : GlaxoSmithKline plc. Breakdown of Net Sales, by Business Segments, 2018
  • Figure 71 : Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
  • Figure 72 : Teva Pharmaceutical Industries Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 73 : Sumitomo Dainippon Pharma Co., Ltd Pharmaceuticals Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 74 : Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 75 : Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceuticals Business Net Sales (%), by Region, 2017
  • Figure 76 : Sumitomo Dainippon Pharma Co., Ltd Breakdown of Net Sales (%), by Product Segment, 2017
  • Figure 77 : Eisai Co., Ltd., Revenue (US$ Mn), 2017–2018
  • Figure 78 : Eisai Co., Ltd., R&D Expenses (US$ Mn), 2017–2018
  • Figure 79 : Eisai Co., Ltd., Breakdown of Net Sales (%), by Region, 2018
  • Figure 80 : Sawai Pharmaceutical, Co.,Ltd., Revenue (US$ Mn), 2017–2018
  • Figure 81 : Sawai Pharmaceutical, Co.,Ltd., Ltd, R&D Expenses (US$ Mn), 2017–2018
  • Figure 82 : Sawai Pharmaceutical, Co.,Ltd., Breakdown of Net Sales (%), by Region, 2018
  • Figure 83 : Amneal Pharmaceuticals LLC., Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
  • Figure 84 : Amneal Pharmaceuticals LLC., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report